NDAQ:KYMR) Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral ...

Image Source: Zacks Investment Research Blueprint is conducting an early-stage study of BLU-808 to assess its unique potency ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Azithromycin is a versatile antibiotic used to treat a wide variety of bacterial infections, including those affecting the ...